| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/05/2011 | CA2526538C Aqueous compositions for disinfection and/or sterilization |
| 04/05/2011 | CA2483028C Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/05/2011 | CA2474479C Composition for inhalation |
| 04/05/2011 | CA2470168C Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 04/05/2011 | CA2379776C A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 04/02/2011 | CA2716231A1 Benzoyl peroxide composition for treating skin |
| 03/31/2011 | WO2011038117A2 Chemically amplified response strategies for medical sciences |
| 03/31/2011 | WO2011037976A2 Pramipexole pharmaceutical formulations |
| 03/31/2011 | WO2011037908A1 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/31/2011 | WO2011037896A2 Polypeptide modification |
| 03/31/2011 | WO2011037760A2 Composite layered hemostasis device |
| 03/31/2011 | WO2011037589A1 Scented and/or flavoured cotton and products therefrom |
| 03/31/2011 | WO2011037550A2 Dry powder combination of tiotropium |
| 03/31/2011 | WO2011037349A2 Target specific drug delivery system, target non-specific long-acting drug delivery system and method of controlling target specificity thereof |
| 03/31/2011 | WO2011037281A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
| 03/31/2011 | WO2011037252A1 Liposome preparation containing spicamycin derivative |
| 03/31/2011 | WO2011037157A1 Eye drops |
| 03/31/2011 | WO2011036879A1 Transferrin liposome preparation |
| 03/31/2011 | WO2011036811A1 Turmeric pigment composition and method for preparing same |
| 03/31/2011 | WO2011036599A1 A dissolvable film strip comprising natural components |
| 03/31/2011 | WO2011036560A2 Glycoconjugate compositions and methods for treatment of hiv |
| 03/31/2011 | WO2011036557A1 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| 03/31/2011 | WO2011036467A1 Products useful in the treatment of haemophilia |
| 03/31/2011 | WO2011036457A1 Peptide clearing agents |
| 03/31/2011 | WO2011036400A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 03/31/2011 | WO2011036357A2 Stable, liquid, ready-to-use ketoprofen formulation |
| 03/31/2011 | WO2011036191A2 Gold –coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| 03/31/2011 | WO2011035988A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application |
| 03/31/2011 | WO2011016049A3 A stable composition of ready-to-use gemcitabine injection |
| 03/31/2011 | WO2010132879A3 Multicomponent degradable cationic polymers |
| 03/31/2011 | WO2010122357A3 Delivery systems |
| 03/31/2011 | WO2010103374A3 Oily suspension containing probiotic bacteria for paradiatric uses |
| 03/31/2011 | WO2010093528A3 On-demand and reversible drug release by external cue |
| 03/31/2011 | WO2010091187A3 Polymeric nanoparticles with enhanced drug-loading and methods of use thereof |
| 03/31/2011 | WO2010065456A4 Flowable pharmaceutical depot |
| 03/31/2011 | WO2010030995A8 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| 03/31/2011 | WO2009129246A3 Compositions and methods for preparing and using same |
| 03/31/2011 | US20110077362 Branched Polymers |
| 03/31/2011 | US20110077309 Humectant composition |
| 03/31/2011 | US20110077308 Agonists of Bitter Taste Receptors and Uses Thereof |
| 03/31/2011 | US20110077217 Selectively depolymerized galactomannan polysaccharide |
| 03/31/2011 | US20110076763 Neoplasm specific antibodies and uses thereof |
| 03/31/2011 | US20110076337 Emulsions containing arylboronic acids and medical articles made therefrom |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076313 Antimicrobial gas impregnated devices and methods |
| 03/31/2011 | US20110076311 Ceramide dispersion |
| 03/31/2011 | US20110076305 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 03/31/2011 | US20110076250 Biodegradable Absorbents and Methods of Preparation |
| 03/31/2011 | US20110076239 Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type |
| 03/31/2011 | CA2775665A1 Turmeric pigment composition and method for preparing same |
| 03/31/2011 | CA2775404A1 Formulations comprising triptan compounds |
| 03/31/2011 | CA2775339A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| 03/31/2011 | CA2775287A1 Polypeptide modification |
| 03/31/2011 | CA2775047A1 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/31/2011 | CA2774893A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application |
| 03/31/2011 | CA2774153A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 03/31/2011 | CA2774081A1 Peptide clearing agents |
| 03/31/2011 | CA2772795A1 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/31/2011 | CA2772220A1 Eye drops |
| 03/30/2011 | EP2302064A1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 03/30/2011 | EP2301976A1 Water-soluble acrylic acid salt polymer and gelling base |
| 03/30/2011 | EP2301968A2 Humanized monoclonal antibody HPAM4 |
| 03/30/2011 | EP2301965A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof |
| 03/30/2011 | EP2301963A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 03/30/2011 | EP2301960A2 Polymer conjugates of mutated neublastin |
| 03/30/2011 | EP2301954A2 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301951A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 03/30/2011 | EP2301659A1 Microcapsules, method of producing the microcapsules and food and drink containing the microcapsules |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301556A1 Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer |
| 03/30/2011 | EP2301555A1 Cream-like o/w type emulsified composition and method for producing same |
| 03/30/2011 | EP2301551A1 Use of alkyl phosphocholines in combination with antitumor medicaments |
| 03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
| 03/30/2011 | EP2301524A1 Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections |
| 03/30/2011 | EP2301356A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 03/30/2011 | EP2300604A1 Nitric oxide compositions and devices and methods for cosmesis |
| 03/30/2011 | EP2300603A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 03/30/2011 | EP2300501A2 A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 03/30/2011 | EP2300052A1 Novel synergistic effects |
| 03/30/2011 | EP2300047A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 03/30/2011 | EP2300045A1 Treatment of metastatic tumors |
| 03/30/2011 | EP2299991A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 03/30/2011 | EP2299988A1 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
| 03/30/2011 | EP2299987A1 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 03/30/2011 | EP2299983A1 Stabilized atypical antipsychotic formulation |
| 03/30/2011 | EP2299979A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299976A2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299974A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 03/30/2011 | EP2299810A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 03/30/2011 | EP2101729B1 Self-microemulsifying drug delivery systems |
| 03/30/2011 | EP2037897B1 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/30/2011 | EP1507515B1 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1361890B1 Influenza vaccine formulations for intradermal delivery |